Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and sells pharmaceuticals and medical devices

Photocure ASA engages as a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment.

It operates through Commercial Franchise and Development Portfolio segments.

The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and partner sales.

The Development Portfolio segment offers development of commercial products and pipeline
products.

The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.

Number of employees : 50 persons.
Sales per Businesses
20152016Delta
NOK (in Million)%NOK (in Million)%
Commercial Franchise134.72100%143.63100% +6.61%
Sales per Regions
20152016Delta
NOK (in Million)%NOK (in Million)%
Partner Countries Europe60.6545%64.4244.9% +6.23%
Nordic Countries38.6728.7%39.0427.2% +0.96%
United States23.0217.1%30.4721.2% +32.36%
Partner Countries Rest of World--2.261.6%-
Managers
NameAgeSinceTitle
Kjetil Hestdal MD, PhD571997President, Chief Executive Officer & Media Contact
Jan Hendrik Egberts MD, MBA592017Chairman
Erik Dahl-2012Chief Financial Officer & IR Contact
Inger Ferner Heglund622006Vice President-Research & Development
Xavier Denis Yon772011Independent Director
Synne Hermansen Røine, MBA382014Independent Director
Tom Edward Pike57-Independent Director
Lars Rønn53-Independent Director
Johanna Holldack, MD-2017Director
Gwen Melincoff-2017Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 21,557,910 16,011,660 74.3% 809 0.0% 74.3%
Shareholders
NameEquities%
Alexander Brask Hansson 3,231,530 15.0%
Fondsfinans Kapitalforvaltning ASA 1,454,000 6.74%
KLP Kapitalforvaltning AS 1,407,232 6.53%
Radiumhospitalets Forskningsstiftelse 1,077,416 5.00%
Hunter Hall Investment Management Ltd. 859,976 3.99%
Danske Capital AS 859,851 3.99%
Eika Kapitalforvaltning AS 366,001 1.70%
Polar Capital LLP 254,476 1.18%
Kjetil Hestdal, MD, PhD 133,873 0.62%
Storebrand Asset Management AS 83,909 0.39%
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
PHOTOCURE ASA-36.67%71
JOHNSON & JOHNSON17.45%364 503
ROCHE HOLDING LTD.4.90%221 492
NOVARTIS8.37%220 936
PFIZER3.08%199 378
MERCK AND COMPANY6.39%171 303
SANOFI6.01%119 827
BAYER11.97%107 019
GLAXOSMITHKLINE3.39%103 206
ELI LILLY AND COMPANY15.11%93 410
BRISTOL-MYERS SQUIBB COMPANY-4.77%91 680
ABBOTT LABORATORIES32.36%88 221
ASTRAZENECA16.10%84 581
ALLERGAN PLC19.50%84 293
NOVO NORDISK A/S7.30%84 148
SHIRE-11.26%48 950
TAKEDA PHARMACEUTICAL CO LTD18.82%40 859
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-16.27%32 966
ASTELLAS PHARMA INC-16.36%25 306
CHUGAI PHARMACEUTICAL CO LTD40.39%23 709
MYLAN NV2.67%20 994
Connections : Photocure ASA
Laboratoires Panpharma SA
Europharma Apotek AS
Pressalit A/S
Mellon Medical BV
Endosense SA
ClanoTech AB
Centre for Human Drug Research
ORCA Therapeutics BV
Acertys Group
Vaccibody AS
Elastagen Pty Ltd.
Lead Pharma Holding BV
Acd Pharmaceuticals AS
Chester Valley Pharmaceuticals, Inc.
Credio as
Goapharma SAS
Biosergen AS
Michelson Diagnostics Ltd.
Medical Instill Technologies, Inc
Triax A/S
Company contact information
Photocure ASA
Hoffsveien 4
Oslo 0275

Phone : +47.22.06.22.10
Fax : +47.22.06.22.18
Web : www.photocure.com
© 2017 People , Fundamentals and Ownership